One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib.
Saved in:
| Title: | One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib. |
|---|---|
| Authors: | Pérez-Lamas L; Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Manzanares M; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Hernández Boluda JC; Hospital Clínico Universitario-INCLIVA, Valencia, Spain., Casado Montero LF; HM hospitales CIOCC, Madrid, Spain., Gómez Casares MT; Hospital Universitario de G.C. Doctor Negrín, Las Palmas de Gran Canaria, Spain., Ayala R; Hospital Universitario, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Xicoy B; Hematology Department, Institut Català d'Oncologia, Institut de Recerca Contra la Leucèmia Josep Carreras, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Ferrer Marin F; Hospital Universitario Morales Meseguer. Centro Regional de Hemodonación. UCAM. CIBERER IMIB-Arrixaca, Murcia, Spain., Ortí G; Hospital Universitari Vall d´Hebron, Barcelona, Spain., De Paz Arias R; Hospital Universitario La Paz-Idipaz, Madrid, Spain., Osorio Prendes S; Hospital Universitario Gregorio Marañón, Madrid, Spain., Perez Lopez R; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain., Mora E; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Ruiz Nuño C; Hospital Universitario Regional de Málaga, Málaga, Spain., Jimenez Velasco A; Hospital Universitario Regional de Málaga, Málaga, Spain., Boqué C; Hospital Duran i Reynals-ICO, Barcelona, Spain., Sierra Pacho M; Hospital Universitario de Salamanca, Salamanca, Spain., Martinez Lopez J; Hospital Universitario, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Carreño-Tarragona G; Hospital Universitario, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Coiras M; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Garcia-Gutierrez V; Hospital Universitario Ramón y Cajal. IRYCIS, Universidad de Alcalá, Madrid, Spain. jvalentingg@gmail.com.; Hospital Universitario Ramón y Cajal. IRYCIS, Ctra. Colmenar Viejo, Fuencarral-El Pardo, 28034, Madrid, Spain. jvalentingg@gmail.com. |
| Source: | Annals of hematology [Ann Hematol] 2026 Jan 20; Vol. 105 (2), pp. 40. Date of Electronic Publication: 2026 Jan 20. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase II |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-026-06806-7 |
